[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360049-105":59,"doc-detail-360049-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","detection-of-methylated-sept9-dna-in-peripheral-blood-for-diagnosis-of-colorectal-cancer","Detection of methylated SEPT9 DNA in peripheral blood for diagnosis of colorectal cancer","","Colorectal cancer (CRC) remains a major cause of cancer-related mortality worldwide, and although colonoscopy is effective, participation is limited by poor compliance. This study evaluates a minimally invasive screening approach using methylated SEPT9 (mSEPT9) DNA in peripheral blood. Using a single-center case-control design and droplet digital PCR (ddPCR), performance is assessed across CRC stages and compared with colorectal adenoma and healthy controls. mSEPT9 shows high specificity and improved accuracy when combined with CEA and CA199.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/detection-of-methylated-sept9-dna-in-peripheral-blood-for-diagnosis-of-colorectal-cancer/360049/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/detection-of-methylated-sept9-dna-in-peripheral-blood-for-diagnosis-of-colorectal-cancer/360049.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biomarker and detection method are used in this study?","Question",{"text":112,"@type":113},"The study analyzes methylated SEPT9 (mSEPT9) DNA in peripheral blood using droplet digital polymerase chain reaction (ddPCR).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does mSEPT9 perform for diagnosing colorectal cancer?",{"text":117,"@type":113},"For CRC patients across all stages, mSEPT9 detection shows sensitivity of 68.35% and specificity of 95.00%.",{"name":119,"@type":110,"acceptedAnswer":120},"Does combining mSEPT9 with other markers improve diagnostic performance?",{"text":121,"@type":113},"Yes. When mSEPT9 is combined with CEA and CA199, the positive detection rate increases to 82.67%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360049,1790468419,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Detection of methylated SEPT9 DNA in peripheral blood for diagnosis of colorectal cancer  \nMengjie Lin 1 , Hong Chen2 and Caifeng Jiang 1   \nCancer Biomarkers Vol. 43(0): 1–7 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/18758592261449027](DOI: 10.1177/18758592261449027)[ ](DOI: 10.1177/18758592261449027)[journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nAbstract  \nBackground: Colorectal cancer (CRC) remains a leading cause of cancer-related death worldwide. Although colonoscopy is effective screening method, its widespread adoption is hampered by poor compliance. Development of patient-friendly screening methods that are minimally invasive is of paramount importance to improve CRC screening participation.  \nMethods: A single-center case-control study was conducted. Blood samples were collected from 119 participants (79 CRC patients, 20 patients with colorectal adenomas, and 20 healthy colonoscopy-negative controls) during May 2023 and March 2025 . The methylated SEPT9 (mSEPT9) DNA in peripheral blood was analyzed by droplet digital polymerase chain reaction (ddPCR).  \nResults: The sensitivity and speciﬁcity of mSEPT9 detection in peripheral blood for diagnosis of all stages of CRC patients was 68.35% and 95.00%, respectively. The positive rate were similar between left-sided CRC and right-sided CRC (65.31% vs 72.41%， p ＞ 0.05). mSEPT9 detection in all healthy people with normal colonoscopy were negative. When mSEPT9 detection was combined with CEA and CA199, positive rate could be raised to 82.67%.  \nConclusions: Blood-based mSEPT9 detection by ddPCR method is a sensitive and speciﬁc method for non-invasive diagnosis of CRC. Combination with CEA and CA19-9 could improve its performance. It may serve as a viable alternative for individuals unwilling or unable to undergo invasive procedures.  \nKeywords  \nSEPT9, methylation, colorectal cancer, droplet digital PCR, diagnosis  \nReceived: 4 August 2025; accepted: 22 April 2026  \nIntroduction  \nColorectal cancer (CRC) is one of the most common malignancies in the world. It is currently the third most common cancer and the second leading cause of cancer-related death worldwide.1–2 The disease burden of CRC is expected to increase to 3.2 million new cases and 1.6 million deaths by 2040 .3 The number of incident cases and deaths of CRC in China has been increasing in the past 30 years and will continue to increase in the next 25 years.4  \nCRC screening is an effective strategy to reduce disease mortality and improve the prognosis of patients through early detection and removal of precancerous lesions and early-stage cancers.5 High-quality screening methods are urgently needed to facilitate the early diagnosis of CRC. At present, traditional methods for CRC screening have certain limitations, such as low sensitivity or speciﬁcity, invasiveness or high cost, requirement for bowel  \npreparation, which limit their application in clinical practice.6 Consequently, screening ofCRC in general population according to the current guidelines remains suboptimal,7 creating a signiﬁcant public health gap and leaving a substantial portion of patients undiagnosed until advanced stages.  \n1 Department of Gastroenterology, The Fourth Afﬁliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, China 2Department of General Surgery, The Fourth Afﬁliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, China  \nCorresponding author:  \nCaifeng Jiang, Department of Gastroenterology, The Fourth Afﬁliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, China.  \nEmail: [cfjiang1999@163.com](cfjiang1999@163.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution  \nNonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://cr","cbCaie0jgeonkPmw","https://ap.wps.com/l/cbCaie0jgeonkPmw","pdf",507114,"English","# Abstract\n# Introduction\n# Materials and method\n## Research object","[{\"question\":\"What biomarker and detection method are used in this study?\",\"answer\":\"The study analyzes methylated SEPT9 (mSEPT9) DNA in peripheral blood using droplet digital polymerase chain reaction (ddPCR).\"},{\"question\":\"How does mSEPT9 perform for diagnosing colorectal cancer?\",\"answer\":\"For CRC patients across all stages, mSEPT9 detection shows sensitivity of 68.35% and specificity of 95.00%.\"},{\"question\":\"Does combining mSEPT9 with other markers improve diagnostic performance?\",\"answer\":\"Yes. When mSEPT9 is combined with CEA and CA199, the positive detection rate increases to 82.67%.\"}]","Detection of methylated SEPT9 DNA in peripheral blood for diagnosis of colorectal cancer | PDF",1790138595,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e89072904d05ef5f9bf5858cedcf610.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98017f258faf36838dce32b87d41dfca.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/142b923e8bf2a35b95901d9867a8fb8a.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb304b1d8805d579a8b9b1a1719a1a68.webp",980,1306]